Health Longevity Secrets
We’re Not Sick. We’re Being Sold | David Etheridge
Health Longevity Secrets
•March 3, 2026•36 min
0
Health Longevity Secrets•Mar 3, 2026
Why It Matters
Understanding how industry‑driven nutrition narratives contribute to chronic illness is crucial for anyone seeking sustainable health improvements. This episode offers a timely, real‑world example of how low‑carb, intermittent fasting strategies can reverse metabolic dysfunction, empowering listeners to take control of their health beyond reliance on medication.
Key Takeaways
- •Traditional meds failed; lifestyle changes reversed his health markers.
- •Intermittent fasting and low‑carb diet lowered insulin, A1C, triglycerides.
- •Food industry’s low‑fat push introduced sugar and seed oils.
- •Doctors can support patients who discontinue meds with improved labs.
- •Whole‑food, protein‑fat diet challenges conventional nutrition advice.
Pulse Analysis
In this episode, David Etheridge shares a personal health odyssey that began with decades of prescription drugs, yo‑yo dieting, and persistent weight gain. After a series of failed medical interventions—including blood‑pressure pills, statins, and a short‑term appetite suppressant—he turned to the principles outlined in his book, *We’re Not Sick, We’re Being Sold*. By adopting a low‑carbohydrate, intermittent‑fasting regimen and gradually shifting to a 16‑8 schedule, he shed 65 pounds, trimmed three pant sizes, and saw dramatic improvements in A1C, triglycerides, and insulin resistance, all while tapering off most of his medications.
Etheridge and host Dr. Robert Lovekin dissect why mainstream nutrition guidance often misleads consumers. The conversation highlights how the low‑fat crusade of the 1970s spurred the food industry to replace fat with refined sugars and industrial seed oils, creating hyper‑palatable products that drive chronic disease. They also explore the biochemical underpinnings of insulin spikes, mTOR activation, and the benefits of protein‑fat‑centric meals that keep blood glucose stable. By debunking the myth that frequent small meals are essential, they argue for strategic fasting windows that allow the body to reset metabolic pathways.
For professionals, the interview underscores a growing willingness among clinicians to monitor patients who voluntarily discontinue certain drugs when objective lab data improve. It also calls for a reevaluation of dietary guidelines: prioritize whole foods, emphasize quality proteins and healthy fats, and limit processed ingredients. This shift could curb the rising tide of obesity, cardiovascular risk, and medication dependence, offering a pragmatic roadmap for both practitioners and health‑conscious adults seeking sustainable longevity.
Episode Description
A high calcium score, a stack of prescriptions, and the nagging sense that “healthy eating” wasn’t working—David Etheridge’s story captures what millions feel but rarely decode. When he shifted from chasing calories to controlling insulin, everything changed: he moved from a 12:12 rhythm to a 16:8 fasting window, led meals with protein and natural fats, saved carbs for later on the plate, and watched both cravings and brain fog fade. The scale moved, but the labs told the real story—A1C from 5.8 to 5.1, triglycerides from 285 to 72, and a dramatically improved lipid ratio.
We dig into why this works. Intermittent fasting gives insulin time to fall, reigniting fat mobilization and cellular repair. Sequential eating blunts glucose spikes and steadies appetite. And building plates around eggs, meat, dairy, and vegetables respects how satiety actually functions. Along the way we confront the legacy of “low fat” guidance that pushed sugar and seed oils into everyday foods, trained us to graze, and stretched ingredient lists while shrinking satiety. David argues for flipping the pyramid: prioritize protein and real fats, add non-starchy vegetables for fiber and micronutrients, treat sugar as an occasional indulgence, and skip the ultra-processed traps.
This isn’t anti-medicine; it’s pro-data. With medical oversight, David watched his markers improve and discussed next steps with a supportive clinician focused on outcomes, not dogma. Even with a high coronary calcium score, the goal becomes halting progression by lowering inflammation and improving insulin sensitivity. We also touch on how AI can translate cryptic test reports into plain English so patients ask better questions and make calmer choices. If you’ve tried to white-knuckle your way through snack culture, this conversation offers a clear, humane alternative: fewer eating windows, protein-first plates, simpler ingredients, and measurable wins. If this resonated, follow the show, share it with a friend who needs hope, and leave a review to help more people find the path back to metabolic health.
Continue this conversation on SubStack: https://robertlufkinmd.substack.com
Get 120 Biomarkers for $99 and CT Calcium scans anywhere in the US. https://www.vitalsvault.com/
Lies I Taught In Medical School : Free sample chapter- https://www.robertlufkinmd.com/lies/
Web: https://robertlufkinmd.com/
X: https://x.com/robertlufkinmd
Youtube: https://www.youtube.com/robertLufkinmd
Instagram: https://www.instagram.com/robertlufkinmd/
LinkedIn: https://www.linkedin.com/in/robertlufkinmd/
TikTok: https://www.tiktok.com/@robertlufkin
Threads: https://www.threads.net/@robertlufkinmd
Facebook: https://www.facebook.com/robertlufkinmd
Bluesky: ...
Show Notes
0
Comments
Want to join the conversation?
Loading comments...